BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31185466)

  • 1. Prevalence and Risk Factors of Cerebral Microbleeds in Patients with Nonvalvular Atrial Fibrillation: An Enhanced T2*-Weighted Angiography Imaging Study.
    Li Z; Cao L; Dong W; Zhang J; Wang C; He X; Huang W; Li Y; Zhao M
    Eur Neurol; 2019; 81(3-4):112-119. PubMed ID: 31185466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of intracerebral haemorrhage in Chinese patients with atrial fibrillation on warfarin with cerebral microbleeds: the IPAAC-Warfarin study.
    Soo Y; Abrigo JM; Leung KT; Tsang SF; Ip HL; Ma SH; Ma K; Fong WC; Li SH; Li R; Ng PW; Wong KK; Liu W; Lam BYK; Wong KSL; Mok V; Chu WCW; Leung TW;
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):428-435. PubMed ID: 30554138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial.
    Takizawa S; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Mizuma A; Yutani S; Nakayama T; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K;
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2143-8. PubMed ID: 26153510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.
    Umemura T; Mashita S; Kawamura T
    PLoS One; 2020; 15(9):e0238456. PubMed ID: 32941455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New cerebral microbleeds in AF patients on non-vitamin K oral anticoagulants or warfarin: One-year follow-up.
    Zhuang L; Zhai L; Qiao S; Hu X; Lai Q; Fu F; Cheng L; Liu L; Liu X; Wang J
    Medicine (Baltimore); 2022 Feb; 101(7):e25836. PubMed ID: 35363159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study.
    Moutzouri E; Glutz M; Abolhassani N; Feller M; Adam L; Gencer B; Del Giovane C; Bétrisey S; Paladini RE; Hennings E; Aeschbacher S; Beer JH; Moschovitis G; Seiffge D; De Marchis GM; Coslovsky M; Reichlin T; Conte G; Sinnecker T; Schwenkglenks M; Bonati LH; Kastner P; Aujesky D; Kühne M; Osswald S; Fischer U; Conen D; Rodondi N
    Int J Stroke; 2023 Dec; 18(10):1219-1227. PubMed ID: 37243540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation.
    Wang J; Zhang J; Shen Y; Xu X
    BMC Cardiovasc Disord; 2019 Apr; 19(1):77. PubMed ID: 30940095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema.
    Charidimou A; Boulouis G; Shams S; Calvet D; Shoamanesh A;
    J Neurol Sci; 2017 Jul; 378():102-109. PubMed ID: 28566143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of atrial fibrillation and association of previous antithrombotic treatment in patients with cerebral microbleeds.
    Horstmann S; Möhlenbruch M; Wegele C; Rizos T; Laible M; Rauch G; Veltkamp R
    Eur J Neurol; 2015 Oct; 22(10):1355-62. PubMed ID: 25557113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New cerebral microbleeds in ischemic stroke patients on warfarin treatment: two-year follow-up.
    Orken DN; Uysal E; Timer E; Kuloglu-Pazarcı N; Mumcu S; Forta H
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1682-5. PubMed ID: 23623660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of non-vitamin K antagonist oral anticoagulant exposure and cerebral microbleeds in Chinese patients with atrial fibrillation.
    Soo Y; Abrigo J; Leung KT; Liu W; Lam B; Tsang SF; Ip V; Ma K; Ip B; Ma SH; Fan F; Chu W; Wong L; Mok V; Leung TW
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):680-686. PubMed ID: 29599284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral Microbleeds Do Not Predict Hemorrhagic Transformation in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease.
    Liu J; Wang D; Li J; Lin J; Xiong Y; Liu B; Wei C; Wu B; Ma Z; Zhang S; Liu M
    Curr Neurovasc Res; 2017; 14(2):104-109. PubMed ID: 28294063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AF.
    Charidimou A; Karayiannis C; Song TJ; Orken DN; Thijs V; Lemmens R; Kim J; Goh SM; Phan TG; Soufan C; Chandra RV; Slater LA; Haji S; Mok V; Horstmann S; Leung KT; Kawamura Y; Sato N; Hasebe N; Saito T; Wong LKS; Soo Y; Veltkamp R; Flemming KD; Imaizumi T; Srikanth V; Heo JH;
    Neurology; 2017 Dec; 89(23):2317-2326. PubMed ID: 29117953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-vitamin k antagonist oral anticoagulants do not increase cerebral microbleeds.
    Saito T; Kawamura Y; Sato N; Kano K; Takahashi K; Asanome A; Sawada J; Katayama T; Hasebe N
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1373-7. PubMed ID: 25847305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of cerebral microbleeds increases with CHADS(2) scores in stroke patients with non-valvular atrial fibrillation.
    Song TJ; Kim J; Lee HS; Nam CM; Nam HS; Heo JH; Kim YD
    Eur J Neurol; 2013 Mar; 20(3):502-508. PubMed ID: 23057579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Microbleeds and Chronic Kidney Disease in Acute Ischemic Stroke Patients with Atrial Fibrillation.
    Yamashiro K; Tanaka R; Kurita N; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104650. PubMed ID: 32024601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of cerebral microbleeds and risk of adverse outcomes in atrial fibrillation: a systematic review and meta-analysis.
    Corica B; Romiti GF; Raparelli V; Cangemi R; Basili S; Proietti M
    Europace; 2022 Oct; 24(9):1395-1403. PubMed ID: 35244694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbleeds and Outcome in Patients With Acute Ischemic Stroke and Atrial Fibrillation Taking Anticoagulants.
    Choi KH; Kim JH; Lee C; Kim JM; Kang KW; Kim JT; Choi SM; Park MS; Cho KH
    Stroke; 2020 Dec; 51(12):3514-3522. PubMed ID: 33028171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial.
    Yokoyama M; Mizuma A; Terao T; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Nogawa S; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K; Takizawa S;
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1918-1925. PubMed ID: 31005561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.